WallStSmart
INCY

Incyte Corporation

NASDAQ: INCY · HEALTHCARE · BIOTECHNOLOGY

$99.10
+1.39% today

Updated 2026-04-29

Market cap
$19.80B
P/E ratio
14.00
P/S ratio
3.69x
EPS (TTM)
$7.08
Dividend yield
52W range
$58 – $112
Volume
1.6M

Incyte Corporation (INCY) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-50.37M$-92.69M$-140.86M$12.36M$97.94M$-161.72M$-94.83M$9.18M$26.26M$86.54M$304.76M$-92.99M$336.23M$710.66M$-124.60M$749.49M$969.94M$496.49M$335.34M$1.41B
Capital expenditures$1.57M$1.15M$698000.00$387000.00$4.11M$3.80M$2.84M$4.27M$27.88M$26.00M$120.28M$111.02M$73.48M$78.06M$187.38M$181.01M$77.83M$47.49M$86.26M$58.87M
Depreciation
Stock-based comp$8.89M$8.89M$15.03M$9.98M$14.86M$28.98M$38.49M$38.40M$62.16M$69.87M$96.20M$133.06M$148.15M$166.59M$177.88M$183.01M$188.42M$215.89M$266.06M$249.35M
Free cash flow$-51.94M$-93.85M$-141.56M$11.97M$93.83M$-165.51M$-97.67M$4.91M$-1.62M$60.53M$184.48M$-204.01M$262.74M$632.59M$-311.98M$568.48M$892.11M$449.00M$249.07M$1.35B
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$16.75M$22.76M$29.94M$26.30M
Share repurchases
Debt repayment
Net change in cash$-144.75M$-49.11M$247.37M$-19.13M$69.14M$130.90M$247.17M$264.46M$668.91M$-321.89M$547.97M$890.61M